Epizyme (EPZM) Tops Q2 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SWKS
9. FISV
10. CVS

Go back to Epizyme (EPZM) Tops Q2 EPS by 7c

Epizyme Announces Second Quarter 2015 Financial Results and Provides Corporate Update

August 6, 2015 7:00 AM EDT

Initiated 5-arm phase 2 study of tazemetostat in NHL Presenting updated data from solid tumor patients in the ongoing phase 1 study of tazemetostat at ESMOs European Cancer Congress in Vienna, Austria on September 26, 2015 As of June 30, 2015, Epizyme had cash and cash equivalents of $237 million, sufficient to fund planned operations through at least the end of the second quarter of 2017 Announced appointment of Rob Bazemore as President and Chief Executive Officer, effective September 10

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Epizyme, Inc.... More